SavedAdd your journal

Journals / Ankara Üniversitesi Tıp Fakültesi Mecmuası / 2019 / Cilt: 72 - Sayı: 1

Reversible Nephrotoxicity of Colistin: A Case Report

Geri Dönüşümlü Kolistin Nefrotoksisitesi: Olgu Sunumu

İrem AKDEMİR KALKAN
Güle ÇINAR
Kemal Osman MEMİKOĞLU
Pages
111–113
Publication Date
2022-10-10
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this article, a case of reversible nephrotoxicity after colistin usage is presented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Both nosocomial and community acquired gram-negative bacterial infections cause serious morbidity and mortality.
📊
Key Findings & Data:However, old antibiotics, which have toxic side effects, should be re-used because of the lack of newly developed antibiotics.
💡
Conclusion & Impact:In this article, a case of reversible nephrotoxicity after colistin usage is presented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Both nosocomial and community acquired gram-negative bacterial infections cause serious morbidity and mortality. However, old antibiotics, which have toxic side effects, should be re-used because of the lack of newly developed antibiotics. One of these is colistin which has both nephrotoxic and neurotoxic side effects. Especially due to nephrotoxicity side effec, serious problems can be experienced in the use of colistin. In this article, a case of reversible nephrotoxicity after colistin usage is presented.

Özet

Hem toplum kökenli hem de hastane kökenli gram negatif bakteri enfeksiyonları ciddi morbidite ve mortalite nedenidir. Ancak yeni geliştirilenantibiyotikler pek olmadığı için toksik yan etkileri bulunan eski antibiyotikler tekrar kullanılmak durumundadır. Bunlardan bir tanesi de hem nefrotoksikhem nörotoksik yan etkisi bulunan kolistindir. Özellikle nefrotoksisite yan etkisi nedeniyle kolistin kullanımında ciddi sıkıntılar yaşanabilmektedir. Bumakalede, kolistin kullanımı sonrasında geri dönüşümlü nefrotoksisite gelişen bir olgu sunulmuştur.

🔖

Cite This Article

KALKAN, İ. A., ÇINAR, G., MEMİKOĞLU, K. O. (2022). Reversible Nephrotoxicity of Colistin: A Case Report. Ankara Üniversitesi Tıp Fakültesi Mecmuası, Cilt: 72 - Sayı: 1, 111–113. https://ajindex.com/articles/443561

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. WHO. Global priority lidt of antibiotic-resistant bacteria guide research, discovery and development of new antibiotics. http://wwwwhoint/ medicines/publications/global-priority-list-antibiotic-resistant-bacteria/ en/.2016
  2. Yahav D, Farbman L, Leibovici L, et al. Colistin: new lessons on an old antibiotic. Clin Microbiol Infect. 2012;18:18-29
  3. Munoz-Price LS, Poirel L, Bonomo RA, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013;13:785-796
  4. Dalfino L, Puntillo F, Ondok MJ, et al. Colistin-associated Acute Kidney Injury in Severely Ill Patients: A Step Toward a Better Renal Care? A Prospective Cohort Study. Clin Infect Dis. 2015;61:1771-1777
  5. Vaara M. Polymyxins and their novel derivatives. Curr Opin Microbiol. 2010;13:574-581
  6. Mendes CA, Burdman EA. [Polymyxins - review with emphasis on nephrotoxicity]. Rev Assoc Med Bras (1992). 2009;55:752-759
  7. Falagas ME, Kasiakou SK. Toxicity of polymyxins: a systematic review of the evidence from old and recent studies. Crit Care. 2006;10:R27
  8. Mert A. Kolistin toksisitesi, ANKEM Derg. 2012; 26(Ek 2):22-26
  9. Temocin F, Erdinc S, Tulek N, et al. Incidence and Risk Factors for Colistin- Associated Nephrotoxicity. Jpn J Infect Dis. 2015;68:318-320
  10. Köksal İ, Kaya S, Gençalioğlu E, Yılmaz G. İntravenöz kolistin kullanımıyla ilişkili olarak gelişen nefrotoksisite, 6.Tepecik Enfeksiyon Günleri, Poster no.17, Muğla (2015)
  11. Wang J, Niu H, Wang R, et al. Safety and efficacy of colistin alone or in combination in adults with Acinetobacter baumannii infection: A systematic review and meta-analysis. Int J Antimicrob Agents. 2018 Nov 14. pii: S0924-8579:30312-1.